Anna Moretti

459 total citations
20 papers, 250 citations indexed

About

Anna Moretti is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Anna Moretti has authored 20 papers receiving a total of 250 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 5 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Anna Moretti's work include Cancer Treatment and Pharmacology (6 papers), Breast Cancer Treatment Studies (5 papers) and BRCA gene mutations in cancer (3 papers). Anna Moretti is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Breast Cancer Treatment Studies (5 papers) and BRCA gene mutations in cancer (3 papers). Anna Moretti collaborates with scholars based in Italy and Lebanon. Anna Moretti's co-authors include Nicla La Verde, Gabriella Farina, Sheila Piva, Valter Torri, Marina Chiara Garassino, Michela Cinquini, Mariagrazia Dotoli, Giovanna Damia, Walter Ukovich and Giorgio Iacobellis and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Anna Moretti

19 papers receiving 242 citations

Peers

Anna Moretti
Liviawati Sutjandra United States
Ashwin N. Ram United States
A Stone United Kingdom
Angela Bowman United Kingdom
Anna Moretti
Citations per year, relative to Anna Moretti Anna Moretti (= 1×) peers Sayaka Kuba

Countries citing papers authored by Anna Moretti

Since Specialization
Citations

This map shows the geographic impact of Anna Moretti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Moretti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Moretti more than expected).

Fields of papers citing papers by Anna Moretti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Moretti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Moretti. The network helps show where Anna Moretti may publish in the future.

Co-authorship network of co-authors of Anna Moretti

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Moretti. A scholar is included among the top collaborators of Anna Moretti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Moretti. Anna Moretti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ruggieri, Lorenzo, Anna Moretti, Rossana Berardi, et al.. (2023). Host-Related Factors in the Interplay among Inflammation, Immunity and Dormancy in Breast Cancer Recurrence and Prognosis: An Overview for Clinicians. International Journal of Molecular Sciences. 24(5). 4974–4974. 5 indexed citations
2.
Verde, Nicla La, Elena Collovà, Livio Blasi, et al.. (2020). Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO Study. Clinical Breast Cancer. 21(5). e489–e496. 7 indexed citations
3.
Cosimo, Serena Di, Nicla La Verde, Anna Moretti, et al.. (2019). Neoadjuvant eribulin mesylate following anthracycline and taxane in triple negative breast cancer: Results from the HOPE study. PLoS ONE. 14(8). e0220644–e0220644. 7 indexed citations
4.
Moretti, Anna, F Bianchi, Giorgio Gherardi, et al.. (2018). Localized morphea after breast implant for breast cancer: A case report. Tumori Journal. 104(6). NP25–NP28. 2 indexed citations
5.
Gherardi, Giorgio, Elena Biagioli, Valter Torri, et al.. (2017). The prognostic role of tumor size in early breast cancer in the era of molecular biology. PLoS ONE. 12(12). e0189127–e0189127. 24 indexed citations
6.
Moretti, Anna, et al.. (2017). Does tumor size in T1-T2 early breast cancer (EBC) still have a prognostic role?. Journal of Clinical Oncology. 35(15_suppl). e12087–e12087. 1 indexed citations
7.
Moretti, Anna, Michele Ghidini, Carmine De Angelis, et al.. (2016). What Medical Oncologist Residents Think about the Italian Speciality Schools: A Survey of the Italian Association of Medical Oncology (AIOM) on Educational, Clinical and Research Activities. PLoS ONE. 11(7). e0159146–e0159146. 1 indexed citations
8.
Verde, Nicla La, Fabio Corsi, Anna Moretti, et al.. (2015). A Targeted Approach to Genetic Counseling in Breast Cancer Patients: The Experience of an Italian Local Project. Tumori Journal. 102(1). 45–50. 6 indexed citations
10.
Torri, Valter, et al.. (2014). Efficacy of biological agents in metastatic triple-negative breast cancer. Cancer Treatment Reviews. 40(5). 605–613. 39 indexed citations
11.
Verde, Nicla La, Elena Collovà, Sara Lonardi, et al.. (2013). Male breast cancer: Clinical features and multimodal treatment in a retrospective survey analysis at Italian centers. ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/). 3 indexed citations
12.
Verde, Nicla La, Elena Collovà, Sara Lonardi, et al.. (2013). Male Breast Cancer: Clinical Features and Multimodal Treatment in a Retrospective Survey Analysis at Italian Centers. Tumori Journal. 99(5). 596–600. 4 indexed citations
14.
Verde, Nicla La, et al.. (2012). Safe chemotherapy and hormone therapy for treating early breast cancer in a glucose 6-phosphate dehydrogenase-deficient patient. Anti-Cancer Drugs. 23(7). 758–760. 4 indexed citations
15.
Verde, Nicla La, Anna Moretti, F Bianchi, et al.. (2012). Multiple Myeloma With Prostate Involvement: A Case Report. Journal of Clinical Oncology. 30(31). e306–e308. 1 indexed citations
16.
Moretti, Anna, et al.. (2011). 5054 POSTER Efficacy of Biological Agents (BA) in Metastatic Triple Negative Breast Cancer (TNBC): a Systematic Review. European Journal of Cancer. 47. S346–S346. 1 indexed citations
17.
Piva, Sheila, Michela Cinquini, Antônio Rossi, et al.. (2010). Risk/benefit profile of bevacizumab in metastatic colon cancer: A systematic review and meta-analysis. Digestive and Liver Disease. 43(4). 286–294. 44 indexed citations
18.
Dotoli, Mariagrazia, et al.. (2010). Modeling and management of a hospital department via Petri nets. ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/). 19 indexed citations
19.
Bonavia, Marco, P Ferri, Anna Moretti, et al.. (2009). Office spirometry can improve the diagnosis of obstructive airway disease in primary care setting. Respiratory Medicine. 103(6). 866–872. 21 indexed citations
20.
Tortorella, Cosimo, A Ottolenghi, Anna Moretti, Emilio Jirillo, & Salvatore Antonaci. (1992). Thymostimulin Administration Modulates Polymorph Metabolic Pathway in Patients with Chronic Obstructive Pulmonary Disease. Immunopharmacology and Immunotoxicology. 14(3). 421–437. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026